- Home
- ABVX vs ECX Comparison
ABVX vs ECX Comparison
Compare ABVX & ECX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABVX
- ECX
- Stock Information
- Founded
- ABVX 2013
- ECX 2017
- Country
- ABVX France
- ECX China
- Employees
- ABVX N/A
- ECX N/A
- Industry
- ABVX
- ECX EDP Services
- Sector
- ABVX
- ECX Technology
- Exchange
- ABVX Nasdaq
- ECX Nasdaq
- Market Cap
- ABVX 511.3M
- ECX 589.5M
- IPO Year
- ABVX N/A
- ECX N/A
- Fundamental
- Price
- ABVX $7.90
- ECX $2.19
- Analyst Decision
- ABVX Buy
- ECX Strong Buy
- Analyst Count
- ABVX 4
- ECX 1
- Target Price
- ABVX $31.50
- ECX $3.20
- AVG Volume (30 Days)
- ABVX 254.8K
- ECX 2.7M
- Earning Date
- ABVX 08-11-2025
- ECX 08-07-2025
- Dividend Yield
- ABVX N/A
- ECX N/A
- EPS Growth
- ABVX N/A
- ECX N/A
- EPS
- ABVX N/A
- ECX N/A
- Revenue
- ABVX $11,444,012.00
- ECX $805,604,079.00
- Revenue This Year
- ABVX $284.20
- ECX $26.72
- Revenue Next Year
- ABVX N/A
- ECX $30.34
- P/E Ratio
- ABVX N/A
- ECX N/A
- Revenue Growth
- ABVX 128.98
- ECX 19.98
- 52 Week Low
- ABVX $4.77
- ECX $0.76
- 52 Week High
- ABVX $14.16
- ECX $3.25
- Technical
- Relative Strength Index (RSI)
- ABVX 65.58
- ECX 73.84
- Support Level
- ABVX $7.41
- ECX $1.62
- Resistance Level
- ABVX $8.13
- ECX $1.96
- Average True Range (ATR)
- ABVX 0.43
- ECX 0.15
- MACD
- ABVX 0.12
- ECX 0.05
- Stochastic Oscillator
- ABVX 92.21
- ECX 86.86
About ABVX Abivax SA American
Abivax SA is a France-based clinical-stage biotechnology company focused on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Company is evaluating its drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of adults with moderately to severely active ulcerative colitis. Its initial focus is on inflammatory bowel diseases, chronic conditions involving inflammation of the gastrointestinal tract, of which the two common forms are UC and CD.
About ECX ECARX Holdings Inc. Ordinary shares
ECARX Holdings Inc is engaged in the sales of system-on-chip core modules, automotive computing platform products, and software stacks as well as the provision of research and development services in the People's Republic of China. The company's core products include infotainment head units, digital cockpits, vehicle chip-set solutions, a core operating system, and an integrated software stack. Beyond this, ECARX is developing a full-stack automotive computing platform. It is engaged in automotive intelligence and networking.